Chapter 085. Neoplasms of the Lung (Part 19) pdf

Chapter 085. Neoplasms of the Lung
(Part 19)

Further Readings
Black C et al: Population screening for lung cancer using computed
tomography: Is there evidence of clinical effectiveness? A systematic review of
the literature. Thorax 62:131, 2007 [PMID: 17287305]
Eberhardt W et al: Chemoradiation paradigm for the treatment of lung
cancer. Nat Clin Pract Oncol 3:188, 2006 [PMID: 16596143]
Hayes DN et al: Gene expression profiling reveals reproducible human lung
adenocarcinoma subtypes in multiple independ
ent patient cohorts. J Clin Oncol
24:5079, 2006 [PMID: 17075127]
Sato M et al: Molecular genetics of lung cancer and translation to the clinic.
J Thorac Oncol 2:327, 2007 [PMID: 17409807]
Stinnett S et al: Role of chemotherapy for palliation in the lun
g cancer
patient. J Support Oncol 5:19, 2007 [PMID: 17265782]
Subramanian J, Govindan R: Lung cancer in never smokers: A review. J
Clin Oncol 25:561, 2007 [PMID: 17290066]
Sun S
et al: Of molecules and cancer stem cells: Novel therapeutic
strategies for lung cancer. J Clin Invest 117, 2007
Wright G et al: Surgery for non-
small cell lung cancer: Systematic review
and meta-
analysis of randomised controlled trials. Thorax 61:597, 2006 [PMID:
16449262]
Bibliography
Albain K et al: Phase III study of con
current chemotherapy and

radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage
IIIA(pN2) non-
small cell lung cancer (NSCLC): Outcomes update of North
American Intergroup 0139 (RTOG 9309). Proc Am Soc Clin Oncol 23:7014,
2005
Alberts WM: Follow-
up and surveillance of the patient with lung cancer:
What do you do after surgery? Respirology 12:16, 2007 [PMID: 17207020]
American College of Chest Physicians: Diagnosis and management of lung
cancer: ACCP evidence-based guidelines. Chest 123:1S, 2003
Arriagada R et al: Cisplatin-
based adjuvant chemotherapy in patients with
completely resected non-small-
cell lung cancer. N Engl J Med 350:351, 2004
[PMID: 14736927]
Bach PB et al: Computed tomography screening and lung cancer outcomes.
JAMA 297:953, 2007 [PMID: 17341709]
Black WC, Baron JA: CT screening for lung cancer: Spiraling into
confusion? JAMA 297:995, 2007 [PMID: 17341714]
Cappuzzo F et al: Epidermal growth factor receptor gene and protein and
gefitinib sensitivity in non-small-cell
lung cancer. J Natl Cancer Inst 97:643, 2005
[PMID: 15870435]
Devaraj A et al: PET/CT in non-
small cell lung cancer staging: Promises
and problems. Clin Radiol 62:97, 2007 [PMID: 17207691]
Douillard JY et al: Adjuvant vinorelbine plus cisplatin versus
observation
in patients with completely resected stage IB-IIIA non-small-
cell lung cancer

(Adjuvant Navelbine International Trialist Association [ANITA]): a randomised
controlled trial. Lancet Oncol 7:719, 2006 [PMID: 16945766]
Dy GK, Adjei AA: Novel tar
gets for lung cancer therapy: Part I, Part II. J
Clin Oncol 20:2881, 3016, 2002
Haiman CA et al: Ethnic and racial differences in the smoking-
related risk
of lung cancer. N Engl J Med 354:333, 2006 [PMID: 16436765]
Hanna N et al: Randomized phase III t
rial of pemetrexed versus docetaxel
in patients with non-small-
cell lung cancer previously treated with chemotherapy.
J Clin Oncol 22:1589, 2004 [PMID: 15117980]
Henschke CI et al: Survival of patients with stage I lung cancer detected on
CT screening. N Engl J Med 355:1763, 2006 [PMID: 17065637]
Hotta K et al: Meta-
analysis of randomized clinical trials comparing
cisplatin to carboplatin in patients with advanced non-small-
cell lung cancer. J
Clin Oncol 22:3852, 2004 [PMID: 15326195]
International Adjuvant Lung Cancer Trial Collaborative Group: Cisplatin-
based adjuvant chemotherapy in patients with completely resected non-
small cell
lung cancer. N Engl J Med 350:351, 2004
Jeong YJ et al: Solitary pulmonary nodules: Detection, characterization,
and g
uidance for further diagnostic workup and treatment. Am J Roentgenol
188:57, 2007 [PMID: 17179346]
Johnson BE, Janne PA: Epidermal growth factor receptor mutations in
patients with non-

small cell lung cancer. Cancer Res 65:7525, 2005 [PMID:
16140912]
K
arnath B: Smoking cessation. Am J Med 112:399, 2002 [PMID:
11904115]
Kato H et al: A randomized trial of adjuvant chemotherapy with uracil-
tegafur for adenocarcinoma of the lung. N Engl J Med 350:1713, 2004 [PMID:
15102997]
Keller S et al: A randomized
trial of postoperative adjuvant therapy in
patients with completely resected stage II or IIIa non-small-
cell lung cancer. N
Engl J Med 343:1217, 2000 [PMID: 11071672]
Kikuchi T, Carbone DP: Proteomics analysis in lung cancer: Challenges
and opportunities. Respirology 12:22, 2007 [PMID: 17207021]
Kobayashi S et al: EGFR mutation and resistance of non-small-
cell lung
cancer to gefitinib. N Engl J Med 352:786, 2005 [PMID: 15728811]
Lynch TJ et al: Activating mutations in the epidermal growth factor
receptor underlying responsiveness of non-small-
cell lung cancer to gefitinib. N
Engl J Med 350:2129, 2004 [PMID: 15118073]
Marcus PM et al: Extended lung cancer incidence follow-
up in the Mayo
Lung Project and overdiagnosis. J Natl Cancer Inst 98:748, 2006
[PMID:
16757699]
Minna JD et al: Focus on lung cancer. Cancer Cell 1:49, 2002 [PMID:
12086887]
Mountain CF: Revisions in the international system for staging lung cancer.

Chest 111:1710, 1997 [PMID: 9187198]
———, Dresler CM: Regional lymph node class
ification for lung cancer
staging. Chest 111:1718, 1997
Mulshine JL: Screening for lung cancer: In pursuit of pre-
metastatic
disease. Nat Rev Cancer 3:65, 2003 [PMID: 12509768]
Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-
small cell lung cancer: A meta-
analysis using updated data on individual patients
from 52 randomised clinical trials. BMJ 311:899, 1996
Olaussen KA et al: DNA repair by ERCC1 in non-small-
cell lung cancer
and cisplatin-based adjuvant chemotherapy. N Engl J Med
355:983, 2006 [PMID:
16957145]
Pao W et al: Targeting the epidermal growth factor receptor tyrosine kinase
with gefitinib in non-small–
cell lung cancer. Semin Cancer Biol 14:33, 2004
[PMID: 14757534]
Peto R et al: Smoking, smoking cessation, and lung c
ancer in the UK since
1950: Combination of national statistics with two case-
control studies. BMJ
321:323, 2000 [PMID: 10926586]
Pieterman RM
et al: Comparison of four chemotherapy regimens for
advanced non-small-cell lung cancer. N Engl J Med 346:92, 2002
Pignon J
et al: Lung Adjuvant Cisplatin Evaluation (LACE): A pooled

analysis of five randomized clinical trials including 4,584 patients. Proc Am Soc
Clin Oncol 24:7008, 2006
Potti A et al. A genomic strategy to refine prognosis in early-stage non-
small-cell lung cancer. N Engl J Med 355:570, 2006 [PMID: 16899777]
Ramalingam S, Belani CP: Recent advances in targeted therapy for non-
small cell lung cancer. Exp Opin Ther Targ 11:245, 2007 [PMID: 17227238]
Sandler A et al: Paclitaxel-carboplatin alone or with bevacizumab for non-
small-cell lung cancer. N Engl J Med 355:2542, 2006 [PMID: 17167137]
Scagliotti GV: The ALPI Trial: The Italian/European experience with
adjuvant chemotherapy in resectable non-
small lung cancer. Clin Cancer Res
11:5011s, 2005
Schiller JH et al: Comparison of four chemotherapy regimens for advanced
non-small-cell lung cancer. N Engl J Med 346:92, 2002 [PMID: 11784875]
Sekido Y et al: Molecular genetics of lung cancer. Annu Rev Med 54:73,
2003 [PMID: 12471176]
Shepherd FA et al. Erlotinib in previously treated non-small-
cell lung
cancer. N Engl J Med 353:123, 2005 [PMID: 16014882]
Special issue dealing with all aspects of the diagnosis and treatment of
small cell lung cancer. Semin Oncol 30:3, 2003
Spira A, Ettinger
DS: Drug therapy: Multidisciplinary management of lung
cancer. N Engl J Med 350:379, 2004 [PMID: 14736930]
Strauss G
et al: Randomized clinical trial of adjuvant chemotherapy with
paclitaxel and carboplatin following resection in Stage IB non-small cell
lung
cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol
9633. Proc Am Soc Clin Oncol 22:7019, 2004

Stroobants S et al: Value of FDG-PET in the management of non-
small cell
lung cancer. Eur J Radiol 45:49, 2003 [PMID: 12499064]
Swensen SJ et al: CT screening for lung cancer: Five-
year prospective
experience. Radiology 235:259, 2005 [PMID: 15695622]
Takano T et al: Epidermal growth factor receptor gene mutations and
increased copy numbers predict gefitinib sensitivity in patients with recurrent non-
small-cell lung cancer. J Clin Oncol 23:6829, 2005 [PMID: 15998907]
Tsao MS et al: Erlotinib in lung cancer—
molecular and clinical predictors
of outcome. N Engl J Med 353:133, 2005 [PMID: 16014883]
Tyczynski JE et al: Lung cancer in Eur
ope in 2000: Epidemiology,
prevention, and early detection. Lancet Oncol 4:45, 2003 [PMID: 12517539]
Unger M: A pause, progress, and reassessment in lung cancer screening. N
Engl J Med 355:1822, 2006 [PMID: 17065645]
Waller D et al: Chemotherapy for patients with non-
small cell lung cancer:
The surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 26:173, 2004
[PMID: 15200998]
Winton T et al: Vinorelbine plus cisplatin vs. observation in resected non-
small-cell lung cancer. N Engl J Med 352:2589, 2005 [PMID: 15972865]
Wistuba II: Genetics of preneoplasia: lessons from lung cancer. Curr Mol
Med 7:3, 2007 [PMID: 17311529]